X-136207109-GACA-G
Position:
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 1P and 5B. PM4_SupportingBS1_SupportingBS2
The NM_001159702.3(FHL1):βc.255_257delβ(p.Asn85del) variant causes a inframe deletion change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000014 in 1,210,202 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 3 hemizygotes in GnomAD. Variant has been reported in ClinVar as Uncertain significance (β β ).
Frequency
Genomes: π 0.0000089 ( 0 hom., 0 hem., cov: 23)
Exomes π: 0.000015 ( 0 hom. 3 hem. )
Consequence
FHL1
NM_001159702.3 inframe_deletion
NM_001159702.3 inframe_deletion
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 9.32
Genes affected
FHL1 (HGNC:3702): (four and a half LIM domains 1) This gene encodes a member of the four-and-a-half-LIM-only protein family. Family members contain two highly conserved, tandemly arranged, zinc finger domains with four highly conserved cysteines binding a zinc atom in each zinc finger. Expression of these family members occurs in a cell- and tissue-specific mode and these proteins are involved in many cellular processes. Mutations in this gene have been found in patients with Emery-Dreifuss muscular dystrophy. Multiple alternately spliced transcript variants which encode different protein isoforms have been described.[provided by RefSeq, Nov 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -4 ACMG points.
PM4
Nonframeshift variant in NON repetitive region in NM_001159702.3. Strenght limited to Supporting due to length of the change: 1aa.
BS1
Variant frequency is greater than expected in population eas. gnomad4_exome allele frequency = 0.0000146 (16/1098131) while in subpopulation EAS AF= 0.000298 (9/30206). AF 95% confidence interval is 0.000155. There are 0 homozygotes in gnomad4_exome. There are 3 alleles in male gnomad4_exome subpopulation. This position pass quality control queck. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting
BS2
High Hemizygotes in GnomAdExome4 at 3 XL gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FHL1 | NM_001159699.2 | c.303_305del | p.Asn101del | inframe_deletion | 3/6 | ENST00000370683.6 | NP_001153171.1 | |
FHL1 | NM_001159702.3 | c.255_257del | p.Asn85del | inframe_deletion | 4/8 | ENST00000394155.8 | NP_001153174.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FHL1 | ENST00000370683.6 | c.303_305del | p.Asn101del | inframe_deletion | 3/6 | 1 | NM_001159699.2 | ENSP00000359717 | P1 | |
FHL1 | ENST00000394155.8 | c.255_257del | p.Asn85del | inframe_deletion | 4/8 | 5 | NM_001159702.3 | ENSP00000377710 |
Frequencies
GnomAD3 genomes AF: 0.00000892 AC: 1AN: 112071Hom.: 0 Cov.: 23 AF XY: 0.00 AC XY: 0AN XY: 34249
GnomAD3 genomes
AF:
AC:
1
AN:
112071
Hom.:
Cov.:
23
AF XY:
AC XY:
0
AN XY:
34249
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000109 AC: 2AN: 182985Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 67573
GnomAD3 exomes
AF:
AC:
2
AN:
182985
Hom.:
AF XY:
AC XY:
0
AN XY:
67573
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000146 AC: 16AN: 1098131Hom.: 0 AF XY: 0.00000825 AC XY: 3AN XY: 363503
GnomAD4 exome
AF:
AC:
16
AN:
1098131
Hom.:
AF XY:
AC XY:
3
AN XY:
363503
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00000892 AC: 1AN: 112071Hom.: 0 Cov.: 23 AF XY: 0.00 AC XY: 0AN XY: 34249
GnomAD4 genome
AF:
AC:
1
AN:
112071
Hom.:
Cov.:
23
AF XY:
AC XY:
0
AN XY:
34249
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
X-linked myopathy with postural muscle atrophy Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 17, 2022 | This variant, c.255_257del, results in the deletion of 1 amino acid(s) of the FHL1 protein (p.Asn85del), but otherwise preserves the integrity of the reading frame. This variant is present in population databases (no rsID available, gnomAD 0.002%). This variant has not been reported in the literature in individuals affected with FHL1-related conditions. ClinVar contains an entry for this variant (Variation ID: 537355). Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Sep 26, 2019 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at